Trial NCT04675827

View at ClinicalTrials.gov 
Org. Study IDs: IJB-EBC-Decrescendo-2020

Last trial update was posted on 2023-09-05

MeSH Interventions

Ado-Trastuzumab Emtansine Maytansine Pertuzumab Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

ER-Negative Breast Cancer HER2-positive Breast Cancer Node-negative Breast Cancer PR-Negative Breast Cancer

Stopping Reasons

Serious concerns on the slow recruitment of the study that impacts the robustness of the scientific rationale and the study financial provision. It aims to assess carefully the situation and to evaluate the potential solutions to overcome the issues.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID